Cargando…

Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study

INTRODUCTION: Several studies have suggested that chronic kidney disease (CKD) may be associated with olfactory impairment. However, to date, the impact of renal replacement therapies has only been partly defined. METHODS: We tested the olfactory function of 235 participants [50 kidney transplant re...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacono, Valentina, Lombardi, Gianmarco, Ottaviano, Giancarlo, Gambaro, Giovanni, Zaza, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803626/
https://www.ncbi.nlm.nih.gov/pubmed/33625692
http://dx.doi.org/10.1007/s40620-021-00983-6
_version_ 1784642906918748160
author Iacono, Valentina
Lombardi, Gianmarco
Ottaviano, Giancarlo
Gambaro, Giovanni
Zaza, Gianluigi
author_facet Iacono, Valentina
Lombardi, Gianmarco
Ottaviano, Giancarlo
Gambaro, Giovanni
Zaza, Gianluigi
author_sort Iacono, Valentina
collection PubMed
description INTRODUCTION: Several studies have suggested that chronic kidney disease (CKD) may be associated with olfactory impairment. However, to date, the impact of renal replacement therapies has only been partly defined. METHODS: We tested the olfactory function of 235 participants [50 kidney transplant recipients (KT), 49 hemodialyzed patients (HD), 30 peritoneal dialysis patients (PD), 51 patients with CKD not on dialysis (ND-CKD) and 55 healthy subjects (HS)] by the Sniffin’ Sticks test (Burghardt®, Wedel, Germany), including the sub-tests for the determination of odor threshold (T), odor discrimination (D), odor identification (I). Each subtest result was then summed up to a composite score, known as the TDI score. The Sino-Nasal Outcome Test-22 (SNOT22), Montreal Cognitive Assessment (MoCA) test and olfactory function Visual Analogue Scale (ofVAS) were also performed. RESULTS: The mean TDI score was significantly lower (and consistent with hyposmia), in HD, PD and ND-CKD compared to HS and KT (ANOVA p < 0.001). Similar results were observed in the I and D tests, and with the T score, though with regard to the latter, only in PD and ND-CKD patients. Multiple comparisons among groups demonstrated no significant differences between KT and HS. After adjustments for confounding factors, a significant linear association was found between both urea (β − 0.03, p < 0.003) and eGFR (β 0.08, p < 0.001) with TDI score. No significant association was observed between the TDI score and the ofVAS score (p = 0.293). CONCLUSIONS: Olfactory impairment affects a large number of CKD patients in the pre-dialysis phase as well as those on dialysis. Kidney transplantation may reverse this condition with a possible positive impact on the quality of life and social behaviors/relationships. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-00983-6.
format Online
Article
Text
id pubmed-8803626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88036262022-02-02 Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study Iacono, Valentina Lombardi, Gianmarco Ottaviano, Giancarlo Gambaro, Giovanni Zaza, Gianluigi J Nephrol Original Article INTRODUCTION: Several studies have suggested that chronic kidney disease (CKD) may be associated with olfactory impairment. However, to date, the impact of renal replacement therapies has only been partly defined. METHODS: We tested the olfactory function of 235 participants [50 kidney transplant recipients (KT), 49 hemodialyzed patients (HD), 30 peritoneal dialysis patients (PD), 51 patients with CKD not on dialysis (ND-CKD) and 55 healthy subjects (HS)] by the Sniffin’ Sticks test (Burghardt®, Wedel, Germany), including the sub-tests for the determination of odor threshold (T), odor discrimination (D), odor identification (I). Each subtest result was then summed up to a composite score, known as the TDI score. The Sino-Nasal Outcome Test-22 (SNOT22), Montreal Cognitive Assessment (MoCA) test and olfactory function Visual Analogue Scale (ofVAS) were also performed. RESULTS: The mean TDI score was significantly lower (and consistent with hyposmia), in HD, PD and ND-CKD compared to HS and KT (ANOVA p < 0.001). Similar results were observed in the I and D tests, and with the T score, though with regard to the latter, only in PD and ND-CKD patients. Multiple comparisons among groups demonstrated no significant differences between KT and HS. After adjustments for confounding factors, a significant linear association was found between both urea (β − 0.03, p < 0.003) and eGFR (β 0.08, p < 0.001) with TDI score. No significant association was observed between the TDI score and the ofVAS score (p = 0.293). CONCLUSIONS: Olfactory impairment affects a large number of CKD patients in the pre-dialysis phase as well as those on dialysis. Kidney transplantation may reverse this condition with a possible positive impact on the quality of life and social behaviors/relationships. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-00983-6. Springer International Publishing 2021-02-24 2022 /pmc/articles/PMC8803626/ /pubmed/33625692 http://dx.doi.org/10.1007/s40620-021-00983-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Iacono, Valentina
Lombardi, Gianmarco
Ottaviano, Giancarlo
Gambaro, Giovanni
Zaza, Gianluigi
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
title Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
title_full Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
title_fullStr Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
title_full_unstemmed Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
title_short Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
title_sort impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803626/
https://www.ncbi.nlm.nih.gov/pubmed/33625692
http://dx.doi.org/10.1007/s40620-021-00983-6
work_keys_str_mv AT iaconovalentina impactofrenalreplacementtherapiesonolfactoryabilityresultsofacrosssectionalcasecontrolstudy
AT lombardigianmarco impactofrenalreplacementtherapiesonolfactoryabilityresultsofacrosssectionalcasecontrolstudy
AT ottavianogiancarlo impactofrenalreplacementtherapiesonolfactoryabilityresultsofacrosssectionalcasecontrolstudy
AT gambarogiovanni impactofrenalreplacementtherapiesonolfactoryabilityresultsofacrosssectionalcasecontrolstudy
AT zazagianluigi impactofrenalreplacementtherapiesonolfactoryabilityresultsofacrosssectionalcasecontrolstudy